Does ORITAVANCIN DIPHOSPHATE Cause Dyspnoea? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Dyspnoea have been filed in association with ORITAVANCIN DIPHOSPHATE (Kimyrsa). This represents 12.7% of all adverse event reports for ORITAVANCIN DIPHOSPHATE.
35
Reports of Dyspnoea with ORITAVANCIN DIPHOSPHATE
12.7%
of all ORITAVANCIN DIPHOSPHATE reports
0
Deaths
6
Hospitalizations
How Dangerous Is Dyspnoea From ORITAVANCIN DIPHOSPHATE?
Of the 35 reports, 6 (17.1%) required hospitalization.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ORITAVANCIN DIPHOSPHATE. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does ORITAVANCIN DIPHOSPHATE Cause?
Multiple use of single-use product (102)
Chills (87)
Infusion related reaction (63)
Off label use (49)
Back pain (41)
Pruritus (36)
Flushing (35)
Tremor (35)
Nausea (33)
Rash (25)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which ORITAVANCIN DIPHOSPHATE Alternatives Have Lower Dyspnoea Risk?
ORITAVANCIN DIPHOSPHATE vs ORLISTAT
ORITAVANCIN DIPHOSPHATE vs ORNIDAZOLE
ORITAVANCIN DIPHOSPHATE vs ORPHENADRINE
ORITAVANCIN DIPHOSPHATE vs OSELTAMIVIR
ORITAVANCIN DIPHOSPHATE vs OSILODROSTAT